Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated- deferoxamine

Journal of Cardiovascular Pharmacology

Volumn 30, Issue 6, 1997, Pages 734-738

  Pieper, Galen M ^a,b   Siebeneich, Wolfgang ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

Deferoxamine; Diabetes mellitus; Endothelium; Hydroxyl radical; Iron; Nitric oxide; Oxidative stress

Indexed keywords

ACETYLCHOLINE; DEFEROXAMINE; GLUCOSE; GLYCERYL TRINITRATE; GLYCOSYLATED HEMOGLOBIN; HETASTARCH; HYDROXYL RADICAL; INDOMETACIN; SCAVENGER; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DRUG CONJUGATION; GLUCOSE BLOOD LEVEL; IRON CHELATION; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROPHYLAXIS; RAT; VASCULAR ENDOTHELIUM; VASCULAR RING;

ANIMALS; BLOOD GLUCOSE; DEFEROXAMINE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HEMOGLOBIN A, GLYCOSYLATED; HETASTARCH; INSULIN; IRON CHELATING AGENTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; VASODILATION;

EID: 0031425142     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199712000-00006     Document Type: Article

References (33)

1. Pieper GM, Gross GJ. Endothelial dysfunction in diabetes. In: Rubanyi GM, et al., ed. Cardiovascular significance of endothelium-derived vasoactive factors. Mount Kisco, NY: Futura Publishing, 1991:223-19.
2. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993;87(suppl V):V-67-76.
3. Kamata K, Miyata N, Abiru T, Kasuya Y. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci 1992;50:1379-87.
4. Poston L, Taylor PD. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci 1995;88:245-55.
5. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 1993;88:2510-6.
6. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 771-6.
7. Hattori Y, Kawasaki H, Abe K, Kanno M. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1991;261(Heart Circ Physiol 30):H1086-94.
8. Langenstroer P, Pieper GM. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am J Physiol 1992;263(Heart Circ Physiol 32):H257-65.
9. Pieper GM, Mei DA, Langenstroer P, O'Rourke ST. Bioassay of endothelium-derived relaxing factor in diabetic rat aorta. Am J Physiol 1992;263(Heart Circ Physiol 32):H676-80.
10. Tesfamariam B, Cohen RA. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 1992;263(Heart Circ Physiol 32):H321-6.
11. Diederich D, Skopec J, Diederich A, Dai FX. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 1994;266(Heart Circ Physiol 35):H1153-61.
12. Rösen P, Ballhausen T, Bloch W, Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia 1995;38:1157-68.
13. Pieper GM, Moore-Hilton G, Roza AM. Evaluation of the mechanism of endothelial dysfunction in the genetically diabetic BB rat. Life Sci 1996;58:PL147-52.
14. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1996;97:22-8.
15. Pieper GM, Langenstroer P, Siebeneich W. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc Res 1997;34:145-56.
16. Pieper GM, Gross GJ, Kalyanaraman B. An ESR study of the nitroxide radical of pentastarch-conjugated deferoxamine. Free Radie Biol Med 1990;9:211-8.
17. Maruyama M, Pieper GM, Kalyanaraman B, Hallaway PE, Hedlund BE, Gross GJ. Effect of hydroxyethyl starch conjugated deferoxamine on myocardial functional recovery following coronary occlusion and reperfusion in dogs. J Cardiovasc Pharmacol 1991;17:166-75.
18. Hallaway PE, Eaton JW, Panter SS, Hedlund BE. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers. Proc Natl Acad Sci USA 1989;86:10108-12.
19. Whitten CF, Gibson GQ, Good MH, Goodwin JF, Brough AJ. Studies in acute iron poisoning. I. Deferoxamine in the treatment of iron poisoning: clinical observations, experimental studies and theoretical considerations. Pediatrics 1965;36:322-35.
20. Roza AM, Slakey DP, Pieper GM, et al. Hydroxethyl starch deferoxamine, a novel iron chelator, delays diabetes in BB rats. J Lab Clin Med 1994;123:556-60.
21. Wohaieb SA, Godin DV. Starvation-related alteration in free radical tissue defense mechanisms in rats. Diabetes 1987;36:169-73.
22. Pieper GM, Siebeneich W, Roza AM, Jordan M, Adams MB. Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J Cardiovasc Pharmacol 1996;28:741-5.
23. Cameron NE, Cotter MA. Neurovascular dysfunction in diabetic rats: potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J Clin Invest 1995;96:1159-63.
24. Ohkuwa T, Sato Y, Naoi M. Hydroxyl radical formation in diabetic rats induced by streptozotocin. Life Sci 1995;56:1789-98.
25. Ghiselli A, Laurenti O, De Mattia G, Maiani G, Ferro-Luzzi A. Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radic Biol Med 1992;13:621-6.
26. Johnson WT, Evans GW. Effects of interrelationship between dietary protein and minerals on tissue content of trace metals in streptozotocin-diabetic rats. J Nutr 1984;114:180-90.
27. Woff SP, Jiany ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 1991;10:339-52.
28. Redmon JB, Pyzdrowski KL, Robertson RP. No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin. Diabetes 1993;42:544-9.
29. Young IS, Tate S, Lightbody JH, McMaster D, Trimble ER. The effects of deferoxamine and ascorbate on oxidative stress in the streptozotocin diabetic rat. Free Radic Biol Med 1995;18:833-40.
30. Angulo J, Sánchez-Ferrer CF, Peiró C, Marín J, Rodríguez-Mañas L. Impairment of endothelium-dependent relaxation by increasing percentages of glycosylated human hemoglobin: possible mechanisms involved. Hypertension 1996;28:583-92.
31. Bucala R, Tracey K, Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 1991; 87: 432-8.
32. Archibald V, Cotter MA, Keegan A, Cameron NE. Contraction and relaxation of aortas from diabetic rats: effects of chronic antioxidant and aminoguanidine treatments. Naunyn Schmiedebergs Arch Pharmacol 1996;353:584-91.
33. Keegan A, Walbank H, Cotter MA, Cameron NE. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 1995;38:1475-8.